None
Quote | Senzime AB (OTCMKTS:SNZZF)
Last: | $0.75 |
---|---|
Change Percent: | 0.0% |
Open: | $0.75 |
Close: | $0.75 |
High: | $0.75 |
Low: | $0.75 |
Volume: | 2,000 |
Last Trade Date Time: | 06/26/2024 03:00:00 am |
News | Senzime AB (OTCMKTS:SNZZF)
UPPSALA, SE / ACCESSWIRE / June 25, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.) announced today that the European Patent Office (EPO) has issued a new patent protecting unique capabilities of the Senzime TetraGraph system. Every year, approximately 100 million patients receive neu...
2024-06-07 05:14:49 ET More on Senzime AB Historical earnings data for Senzime AB (publ) Financial information for Senzime AB (publ) Read the full article on Seeking Alpha For further details see: Senzime secures contract with a children's hospital in the...
Message Board Posts | Senzime AB (OTCMKTS:SNZZF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Senzime AB Company Name:
SNZZF Stock Symbol:
OTCMKTS Market:
UPPSALA, SE / ACCESSWIRE / June 25, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.) announced today that the European Patent Office (EPO) has issued a new patent protecting unique capabilities of the Senzime TetraGraph system. Every year, approximately 100 million patients receive neu...
UPPSALA, SWEDEN / ACCESSWIRE / June 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Uppsala, Sweden - Senzime AB today announced that it has secured a purchasing contract with the number one ranked children's hospital system in the United States for its TetraGraph® quantitative neuromuscular moni...
UPPSALA, SWEDEN / ACCESSWIRE / May 21, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) In a new clinical study published in the high-impact Anesthesiology journal, a team of US-based researchers compared the accuracy and precision of commercially available neuromuscular block monitors. The study confirms...